Welcome to the e-CCO Library!

P331: Composite outcomes in Crohn’s disease: a systematic review and meta-analysis of observational studies
Year: 2022
Source: ECCO'22
Authors: Estevinho, M.M.(1);Sottomayor, C.(2);Alves, C.(3);Santago, M.(4);Ministro, P.(5);Lago, P.(6);Correia, L.(7);Gonçalves, R.(8);Carvalho, D.(9);Portela, F.(10);Dias, C.C.(11);Dignass, A.(12);Danese, S.(13);Peyrin-Biroulet, L.(14);Magro, F.(15);
Created: Friday, 11 February 2022, 3:52 PM
P331: Development of a novel transabdominal ultrasound disease activity score in patients with ulcerative colitis (UCUS score)
Year: 2018
Source: ECCO '18 Vienna
Authors:

Y. Hashimoto1*, N. Kume1, K. Sato1, T. Kanemura1, A. Haga1, Y. Ishii1, M. Nishio1, H. Otake1, N. Takahashi1, T. Ogashiwa1, M. Izumi2, A. Hanzawa2, H. Yonezawa2, Y. Saigusa3, S. Maeda4, H. Kimura1, R. Kunisaki1

Created: Thursday, 21 February 2019, 9:14 AM
P331: Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gecse K.B.*1, Vegh Z.1, Kurti Z.1, Rutka M.2, Farkas K.2, Golovics P.A.1, Lovasz B.D.1, Gonczi L.1, Banai J.3, Bene L.4, Gasztonyi B.5, Kristof T.6, Lakatos L.7, Miheller P.8, Nagy F.2, Palatka K.9, Papp M.9, Patai A.10, Salamon A.11, Szamosi T.3, Szepes Z.2, Toth G.T.12, Vincze A.13, Molnar T.2, Lakatos P.L.1

Created: Wednesday, 20 February 2019, 10:36 AM
P331: Real-world assessment of biological treatment of inflammatory bowel disease at an Austrian Referral Centre: the ULTIMATE study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. P. Gröchenig*1, E. Walter2, A. Redl3, M. Bresztowanszky1, K. Steidl1, F. Siebert1, G. Novacek5

Created: Friday, 22 February 2019, 9:41 AM
P331: Risk Factors and Prediction Model for Fecal Incontinence in Patients with Crohn's Disease: A Multicenter Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wang, C.(1)*;Yang, F.(2);Qiao, L.(1);Chen, Q.(1);Chen, H.(1);Li, Y.(3);Zhang, X.(4);Liao, X.(5);Cao, L.(3,6);Xu, H.(1);Xiang, Y.(1);Wang, X.(7);Yang, B.(1);
Created: Friday, 14 July 2023, 11:05 AM
P331: The safety of tioguanine exposure during pregnancy: a case series of seventy-three pregnancies
Year: 2021
Source: ECCO'21 Virtual
Authors: Crouwel, F.(1);Simsek, M.(1);De Boer, M.A.(2);Mulder, C.J.J.(1);Buiter, H.J.C.(3);De Boer, N.K.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P332 Mindfulness-based stress reduction and cognitive intervention improve the health-related quality-of-life and ability to work in Crohn’s disease patients: A randomised controlled trial
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Schwartz1, R. Sergienko2, G. Goren3, S. Reggev3, M. Friger2, A. Nemirovsky4, A. Monsonego4, D. Greenberg5, O. Sarid3, V. Slonim-Nevo3, S. Odes6, Israeli IBD NUcleua IIRN

Created: Thursday, 30 January 2020, 10:12 AM
P332: A treat-to target strategy guided by pan-enteric valuation in paediatric Crohn’s disease improves outcomes at 2 years
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Oliva1*, S. Cohen2, M. Aloi1, S. Mallardo1, F. Viola1, G. D'Arcangelo1, F. Maccioni3, C. Hassan4, P. Papoff5, S. Cucchiara1

Created: Thursday, 21 February 2019, 9:14 AM
P332: External validation of intestinal ultrasound scores to detect endoscopic activity in children and adults with Crohn's disease: A prospective cohort study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Aronskyy, I.(1);Spencer, E.(1);Kellar, A.(1);Pittman, N.(1);Dubinsky, M.(1);Dolinger, M.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P332: Group-based Acceptance and Commitment Therapy (ACT) is acceptable and effective at reducing psychological distress in patients with Inflammatory Bowel Disease (IBD).
Year: 2022
Source: ECCO'22
Authors: Duff, A.(1);De Petrillo, A.(2);Reynolds, D.(3);Bangura, E.(4);Pavilidis, P.(1);Mawdsley, J.(1);
Created: Friday, 11 February 2022, 3:52 PM
P332: Influence of mesalamine maintenance therapy on progression of ulcerative proctitis in Korea
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. S. Choi1, W. J. Kim*2, H.-J. Jung3, J. K. Kim1, K.-H. Song3

Created: Friday, 22 February 2019, 9:49 AM
P332: Multinational comparisons of practices in overseas travel in Crohn’s disease and ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Greveson*1, C. Inglis2, S. Ben-Horin3, S. Ghaly4, Y. Yunki5, R. Leong5

Created: Friday, 22 February 2019, 9:41 AM
P332: Population pharmacokinetics of ozanimod and active metabolite CC112273 in patients with ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Shen, J.(1);Tatosian, D.(1);Sid-Otmane, L.(2);Teuscher, N.(3);Chen, L.(1);Zhang, P.(1);Tirucherai, G.S.(1);Chitakara, D.(1);Marta, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P332: Treat to target in Crohn's disease: ultrasonographic response is associated with better outcomes
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Zorzi F., Lolli E., Onali S., Petruzziello C., Fantini M.C., Biancone L., Monteleone G., Calabrese E.

Created: Wednesday, 20 February 2019, 10:36 AM
P333 Biologic longevity: Withdrawal of drugs due to remission is rare in clinical practice
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Sharma, G. Cunningham, P. Dawson, F. D’Errico, S. Honap, S. Lim, R. Luber, S. Meade, P. Pavlidis, R. Reynolds, P. Irving

Created: Thursday, 30 January 2020, 10:12 AM
P333: Associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Uchino*1, H. Ikeuchi1, T. Bando1, T. Chohno1, H. Sasaki1, Y. Horio1, R. Kuwahara1, T. Minagawa1, Y. Goto1

Created: Friday, 22 February 2019, 9:41 AM
P333: Changing patterns of biological therapy use with the introduction of biosimilars in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mortier K.1, Arnott I.*2, Russell R.K.3 UK Inflammatory Bowel Disease (IBD) Audit Steering Group

Created: Wednesday, 20 February 2019, 10:36 AM
P333: Early intestinal ultrasound remission is associated with endoscopic healing after one year of infliximab therapy in Crohn's disease: a multicentre prospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Revés, J.(1)*;Morão, B.(1);Nascimento, C.(1);Frias-Gomes, C.(1);Cúrdia Gonçalves, T.(2);Freitas, M.(2);Castro, F.(2);Moreira, M.J.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
Created: Friday, 14 July 2023, 11:05 AM
P333: Endoscopic severity and CRP predict failure of medical rescue therapy in patients with acute severe ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Kakkadasam Ramaswamy, P.(1);Subhaharan, D.(1);Willmann, L.(1);Edwards, J.(1);Shukla, D.(1);Bhullar, M.(1);Moattar, H.(1);Dorrington, A.(1);Ishaq, N.(1);McIvor, C.(2);Mohsen, W.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P333: Long-term efficacy and safety of thiopurines in patients with steroid-dependent ulcerative colitis: a retrospective investigation
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. Yokoyama*, T. Sato, M. Kawai, Y. Kita, K. Kamikozuru, T. Miyazaki, M. Iimuro, N. Hida, S. Nakamura

Created: Friday, 22 February 2019, 9:49 AM